Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
| General Information of Drug (ID: DR2148) | ||||||
|---|---|---|---|---|---|---|
| Drug Name |
Hydroxydaidzein
|
|||||
| Synonyms |
MolPort-000-165-583; SCHEMBL571127; 4'',7,8-trihydroxyisoflavone; 4',7,8-Trihydroxyisoflavone; 4H-1-Benzopyran-4-one, 7,8-dihydroxy-3-(4-hydroxyphenyl)-; 7,4'-Trihydroxyisoflavone; 7,8,4''-trihydroxyisoflavone; 7,8,4'-Trihydroxyisoflavone; 7,8-Dihydroxy-3-(4-hydroxy-phenyl)-chromen-4-one; 7,8-Dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one; 7,8-Dihydroxy-3-(4-hydroxyphenyl)chromen-4-one; 75187-63-2; 8-Hydroxydaidzein; AC1NV1M1; BMZFZTMWBCFKSS-UHFFFAOYSA-N; CHEMBL242739; CTK5E1244; DTXSID20226169; NSC 678112; NSC678112
|
|||||
| Indication | Discovery agent | Investigative | [1] | |||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
| Pharmaceutical Properties | Molecular Weight | 270.24 | Topological Polar Surface Area | 87 | ||
| Heavy Atom Count | 20 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| Cross-matching ID | ||||||
| The Metabolic Roadmap of This Drug | |||||
|---|---|---|---|---|---|
| The Full List of Drug Metabolites (DM) of This Drug | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
| The Full List of Metabolic Reaction (MR) of This Drug | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
| Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.


